Abacavir hydroxyacetate |
| Catalog No.GC66453 |
Abacavir hydroxyacetate는 IL-20 및 PRINS의 경구 활성 억제제입니다. 821d96072c2d58d8970e76f526b0f6b8Abacavir hydroxyacetate는 면역 조절제로서 건선의 피부 증식률을 감소시킵니다. 821d96072c2d58d8970e76f526b0f6b8Abacavir hydroxyacetate는 염증성 피부 문제 연구에 사용할 수 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1446418-48-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Abacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of skin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory skin problems[1][2].
Abacavir hydroxyacetate (10-20 mg/kg; p.o. once) effectively controls psoriasis of mice[2].
| Animal Model: | 6 to 8-week-old male and female SCID mice with implantation of psoriatic tissue[2] |
| Dosage: | 10 and 20 mg/kg |
| Administration: | Oral gavage; 10-20 mg/kg once |
| Result: | Decreased the concentration of PRINS and 1L-20, and reduced the lesion area of skin. Showed a better effect than methotrexate in controlling psoriasis. |
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *